Jamie L Jolly - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jamie L Jolly

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Expert Review of Cardiovascular Therapy|October 27, 2004

Recent advances in the secondary prevention of coronary heart diseaseAngie Veverka, Jamie L Jolly

The Annals of Pharmacotherapy|July 11, 2006

Nebivolol: a third-generation beta-adrenergic blockerAngie Veverka, Donald S Nuzum, Jamie L Jolly

Journal of the American Pharmacists Association : Japha|June 3, 2006

Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individualsKathleen A Snella, Ann E Canales, Brian K Irons, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Expert Review of Cardiovascular Therapy|October 27, 2004

Recent advances in the secondary prevention of coronary heart diseaseAngie Veverka, Jamie L Jolly

The Annals of Pharmacotherapy|July 11, 2006

Nebivolol: a third-generation beta-adrenergic blockerAngie Veverka, Donald S Nuzum, Jamie L Jolly

Journal of the American Pharmacists Association : Japha|June 3, 2006

Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individualsKathleen A Snella, Ann E Canales, Brian K Irons, et al.

Pageof 1